摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(4-Hydroxyphenyl)semicarbazide | 73469-92-8

中文名称
——
中文别名
——
英文名称
4-(4-Hydroxyphenyl)semicarbazide
英文别名
1-amino-3-(4-hydroxyphenyl)urea
4-(4-Hydroxyphenyl)semicarbazide化学式
CAS
73469-92-8
化学式
C7H9N3O2
mdl
——
分子量
167.167
InChiKey
NTSXSCNGNVDTJM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.4
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    87.4
  • 氢给体数:
    4
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    2-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-ylamino)acetic acid4-(4-Hydroxyphenyl)semicarbazide三氯氧磷 作用下, 以73%的产率得到4-[(5-[4-hydroxylphenylamino]-1,3,4-oxadiazol-2-yl)methylamino]-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one
    参考文献:
    名称:
    Discovery of novel antitubercular 1,5-dimethyl-2-phenyl-4-([5-(arylamino)-1,3,4-oxadiazol-2-yl]methylamino)-1,2-dihydro-3H-pyrazol-3-one analogues
    摘要:
    In search of potential therapeutics for tuberculosis, we describe herewith the synthesis, characterization and antimycobacterial activity of 1,5-dimethyl-2-phenyl-4-([5-(arylamino)-1,3,4-oxadiazol-2-yl]methylamino)-1,2-dihydro-3H-pyrazol-3-one analogues. Among the synthesized compounds, 4-1(5-1( 4-fluorophenylamino[-1,3,4-oxadiazol-2-yl)methylamino]-1,2-dihydro-1,5-dimethyl-2-Phenylpyrazol-3-one (4a) was found to be the most promising compound active against Mycobacterium tuberculosis H(37)Rv and isoniazid resistant M. tuberculosis with minimum inhibitory concentrations, 0.78 and 3.12 mu g/mL, respectively, free from any cytotoxicity (>62.5 mu g/mL). (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.12.014
  • 作为产物:
    描述:
    N(hydroxy-4 phenyl) carbamate de phenyle 在 hydrazine hydrate 作用下, 以 乙腈 为溶剂, 反应 3.0h, 以97%的产率得到4-(4-Hydroxyphenyl)semicarbazide
    参考文献:
    名称:
    通过氨基甲酸苯酯由相应的胺和肼制备取代的氨基脲
    摘要:
    开发了一种简单的合成方法,用于将胺和肼转化为取代的氨基脲。所需的胺和氯甲酸苯酯之间最初的缩合成氨基甲酸苯酯,然后在碱性条件下加入肼。该反应可耐受各种官能团,条件温和,收率高。
    DOI:
    10.1016/j.tetlet.2014.01.052
点击查看最新优质反应信息

文献信息

  • Preparation of substituted semicarbazides from corresponding amines and hydrazines via phenyl carbamates
    作者:Rebecca Hron、Branko S. Jursic
    DOI:10.1016/j.tetlet.2014.01.052
    日期:2014.2
    A simple synthetic procedure for the conversion of amines and hydrazines into substituted semicarbazides was developed. The initial condensation between the desired amine and phenyl chloroformate into phenyl carbamate is followed by the addition of hydrazine under basic conditions. The reaction is tolerable to a variety of functional groups, with mild conditions and high percent yields.
    开发了一种简单的合成方法,用于将胺和肼转化为取代的氨基脲。所需的胺和氯甲酸苯酯之间最初的缩合成氨基甲酸苯酯,然后在碱性条件下加入肼。该反应可耐受各种官能团,条件温和,收率高。
  • Method of processing a silver halide color photographic material and a
    申请人:Fuji Photo Film Co., Ltd.
    公开号:US05064751A1
    公开(公告)日:1991-11-12
    A method for processing a silver halide color photographic material including the step of developing the silver halide color photographic material with a color developing solution containing at least one aromatic primary amine developing agent and at least one hydrazide represented by the following formula (I) or (II) R.sup.1 --X.sup.1 --NHNH--R.sup.2 (I) in which X.sup.1 represents --CO--, --SO.sub.2 -- or ##STR1## R.sup.1 represents a hydroxyl group, a hydroxyamino group, carbamoyl group, a hydrazinocarbonyl group, an amino group, or a hydrazino group; and R.sup.2 represents a hydrogen atom, an alkyl group, or an aryl group; provided that the R.sup.1 or R.sup.2 groups of at least two of the hydrazide groups may be linked to form a dimer or higher polymer of the hydrazide. R.sup.3 --X.sup.2 --NHNH--R.sup.4 (II) in which X.sup.2 represents --CO-- or --SO.sub.2 --; R.sup.3 represents a hydrogen atom, an alkyl group, an aryl group, a heterocyclic group, an alkoxy group, or an aryloxy group; and R.sup.4 represents a hydrogen atom, an alkyl group or an aryl group; provided that the R.sup.3 or R.sup.4 groups of at least two of the hydrazide groups may be linked to form a dimer or higher polymer of the hydrazide. The method provides increased developer stability and reduced fog formation, particularly in continuous processing.
    一种处理银卤化物彩色照相材料的方法,包括以下步骤:用含有至少一种芳香族原始胺显影剂和至少一种由以下公式(I)或(II)表示的肼类化合物的显色显影溶液显影银卤化物彩色照相材料。其中,X1代表—CO—、—SO2—或##STR1##,R1代表羟基、羟基氨基、氨甲酰基、肼甲酰基、氨基或肼基;R2代表氢原子、烷基或芳基;但至少两个肼基的R1或R2基团可连接形成肼的二聚体或更高聚合物。R3—X2—NHNH—R4(II)其中,X2代表—CO—或—SO2—,R3代表氢原子、烷基、芳基、杂环基、烷氧基或芳氧基;R4代表氢原子、烷基或芳基;但至少两个肼基的R3或R4基团可连接形成肼的二聚体或更高聚合物。该方法提供了增加显影剂稳定性和减少雾化现象的效果,特别是在连续处理中。
  • Kramer, Claus-Ruediger; Beck, Lothar, Zeitschrift fur Chemie, 1980, vol. 20, # 1, p. 25 - 26
    作者:Kramer, Claus-Ruediger、Beck, Lothar
    DOI:——
    日期:——
  • [EN] INDAN-1,3-DIONE AND INDAN-1,2,3-TRIONE DERIVATIVES, PROCESSES FOR THE PREPARATION OF SAME AND THEIR APPLICATION AS THERAPEUTIC AGENTS<br/>[FR] DERIVES D'INDANE-1,3-DIONE ET D'INDANE-1,2,3-TRIONE, LEURS PROCEDES DE PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
    申请人:INNOTHERA
    公开号:WO1993020045A1
    公开(公告)日:1993-10-14
    (EN) Compounds of formula (I) used as therapeutic agents. R2 and R3 are independently H, C1-C4 alkoxy or OH and (A, B) = (oxygen, oxygen) in which case either R or R1 is OH, halogen, secondary amino or tertiary amine while the other denotes NHNHCONHR4 or R and R1 together form =N-NH-CX-NHR5, =N-NH-CX-N(phenyl)2, =N-NH-CX-NH-NH-R5, =N-NH-C(SCH3)=N-R6 or =N-N=C(SCH3)-NH-R6; or (A, B) = (N-OH, oxygen) in which case R and R1 together form =N-NH-CX-NHR5 or =N-NH-CX-N(phenyl)2; or (A, B) = (N-NH-CX-NHR5, oxygen) in which case R and R1 together form =N-NH-CX-NHR5; or (A, B) = (N-OH, N-OH) in which case R and R1 together form =N-NH-CX-NHR5 or =N-NH-CX-N(phenyl)2.(FR) Composés utiles en thérapeutique de formule (I) dans laquelle R2 et R3 représentent indépendamment l'un de l'autre H, alkoxy en C1-C4 ou OH et (A, B) = (oxygène, oxygène), auquel cas l'un parmi R et R1 représente OH, halogène, amino secondaire ou amine tertiaire et l'autre représente NHNHCONHR4 ou bien R et R1 forment ensemble =N-NH-CX-NHR5, =N-NH-CX-N(phényle)2, =N-NH-CX-NH-NH-R5, =N-NH-C(SCH3)=N-R6 ou =N-N=C(SCH3)-NH-R6; ou (A, B) = (N-OH, oxygène), auquel cas R et R1 forment ensemble =N-NH-CX-NHR5 ou =N-NH-CX-N(phényle)2; ou (A, B) = (N-NH-CX-NHR5, oxygène), auquel cas R et R1 forment ensemble =N-NH-CX-NHR5; ou (A, B) = (N-OH, N-OH), auquel cas R et R1 forment ensemble =N-NH-CX-NHR5 ou =N-NH-CX-N(phényle)2.
  • Synthesis of N-aryl and N-arylcarbamoylamino derivatives of 1,3-diazinane-5-carboxamide and their activity against glioblastoma LN-229 cell line
    作者:Rebecca J. Hron、Branko S. Jursic、Donna M. Neumann
    DOI:10.1016/j.bmc.2016.09.074
    日期:2016.12
    Six structural motifs based on the initial (lead) structure of merbarone were designed, prepared, and tested against the glioblastoma LN-229 cell line. Three different structural moieties were modified in the search for optimal glioblastoma activity: the 1,3-diazinane moiety, the aryl moiety, and the heteroatom linker. Calculated molecular descriptors such as lipophilicity (ClogP), acidic strength (calculated pK(a)), and polar surface area (PSA) were used to design a diverse structural library of these compounds. From six different structural motifs and 136 compounds, a handful of examples with moderate (100 mu g/ml), good (10 mu g/ml) and excellent (1 mu g/ml) glioblastoma activity were elucidated. (C) 2016 Published by Elsevier Ltd.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐